Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Enzymatic Therapy is a prominent manufacturer of dietary supplements and natural health products, recognized for its commitment to science-based formulations. Established in 1981 and based in Green Bay, Wisconsin, the company specialized in 'pharmaceutical-grade' natural medicines, including the popular Remifemin and Pearls probiotics lines. In 2008, the company was acquired by Schwabe North America, the parent organization of Nature's Way, leading to the integration of its product portfolio. The brand remains a staple in the health food and specialty retail channels, focusing on therapeutic areas such as digestive health, stress, and women's health. Its legacy continues through the Nature's Way brand, which maintains the high quality and testing standards established by Enzymatic Therapy.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Enzymatic Therapy.